Pathways between preventive cancer screening and citizenship
Monday, November 2, 2015
: 3:30 p.m. - 3:50 p.m.
Background: Cancer is the second leading cause of death among immigrants, but overall immigrants remain a largely unexplored vulnerable population in regards to cancer screening. The passing of the ACA which provides insurance access to lawful residents, along with emerging evidence on length of residence in the U.S. and cancer screening among immigrant women, suggests the importance in further research regarding factors associated with citizenship. Methods: Structural equation modeling is used to examine pathways between citizenship and mammogram in a pooled sample of women ages 40 and older from the National Health Interview Survey in 2000, 2005, and 2010 (N=12,014). We analyzed the data with Mplus 6.12, using the weighted least squared estimator with mean and variance adjusted (WLSMV). Results: Lack of citizenship decreases one’s chance of receiving a mammogram, regardless of their race and SES (CFI=.962 and RMSEA=.023; (p<.001). Discussion: This study addresses the emerging importance of immigration policies for lawful residence and breast cancer screening by examining the pathways through which citizenship influences a woman’s likelihood of receiving a mammogram. While access to insurance remains an important pathway for an immigrant woman to receive a mammogram, citizenship remains an independent major factor in this process and should continue to be explored as a structural barrier for breast cancer screening among this vulnerable population.
Public health or related public policy
Identify the pathways between preventive cancer screening and citizenship.
Keyword(s): Public Health Policy, Cancer Prevention and Screening
Presenting author's disclosure statement:
Qualified on the content I am responsible for because: I have been funded to conduct research on health disparities that affect vulnerable populations, specifically immigrant and Latino populations.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines,
and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed
in my presentation.